Jeffrey Yordon
Chief Executive Officer, Sagent Pharmaceuticals, Inc.
Companies
- Athenex, Inc.Officer Jun 13, 2017 to Aug 15, 20221
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Athenex, Inc.245,943 shares2Aug 3, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 3, 2022Shares withheld for tax 3,663 shares at $0.58 of Athenex, Inc.2
- Aug 3, 2022Exercised options 12,500 shares of Athenex, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAthenex, Inc., Officer
- 2